Details about Valerie Seror

Access statistics for papers by Valerie Seror.

Last updated 2025-01-08. Update your information in the RePEc Author Service.

Short-id: pse513

Working Papers

2021

1. COVID-19-related attitudes, risk perceptions, preventive behaviours and economic impact in sub-Saharan African countries: Implementing a longitudinal phone-based survey protocol in rural Senegalese households
   Post-Print, HAL

2020

2. The French public's attitudes to a future COVID-19 vaccine: The politicization of a public health issue
   Post-Print, HAL View citations (21)

2018

3. Discounting Health and Money: New Evidence Using A More Robust Method
   Post-Print, HAL View citations (23)
   See also Journal Article Discounting health and money: New evidence using a more robust method, Journal of Risk and Uncertainty, Springer (2018) View citations (24) (2018)
4. Recours aux arrêts-maladie et au temps partiel thérapeutique après un diagnostic de cancer
   SciencePo Working papers Main, HAL
   Also in Post-Print, HAL (2018)
5. Situation professionnelle cinq ans après un diagnostic de cancer
   Post-Print, HAL
   Also in SciencePo Working papers Main, HAL (2018)
6. Trajectoires professionnelles après un diagnostic de cancer
   SciencePo Working papers Main, HAL
   Also in Post-Print, HAL (2018)

2015

7. The labour market, psychosocial outcomes and health conditions in cancer survivors: protocol for a nationwide longitudinal survey 2 and 5 years after cancer diagnosis (the VICAN survey)
   Post-Print, HAL

2013

8. Time preferences, socioeconomic status and smokers' behaviour, attitudes and risk awareness
   Post-Print, HAL View citations (16)

2012

9. Responses to increasing cigarette prices in France: How did persistent smokers react?
   Post-Print, HAL
   See also Journal Article Responses to increasing cigarette prices in France: How did persistent smokers react?, Health Policy, Elsevier (2012) (2012)

2007

10. Premières applications de la pharmacogénique en oncologie
    Post-Print, HAL

Journal Articles

2021

1. Préférences et perceptions face au risque: quels enseignements pour des applications à la santé ?
   Revue française d'économie, 2021, XXXVI, (1), 15-56

2019

2. France's citizen consultation on vaccination and the challenges of participatory democracy in health
   Social Science & Medicine, 2019, 220, (C), 73-80 View citations (2)
3. The cost-effectiveness of neonatal versus prenatal screening for congenital toxoplasmosis
   PLOS ONE, 2019, 14, (9), 1-17

2018

4. Discounting health and money: New evidence using a more robust method
   Journal of Risk and Uncertainty, 2018, 56, (2), 117-140 View citations (24)
   See also Working Paper Discounting Health and Money: New Evidence Using A More Robust Method, Post-Print (2018) View citations (23) (2018)

2012

5. Responses to increasing cigarette prices in France: How did persistent smokers react?
   Health Policy, 2012, 106, (2), 169-176
   See also Working Paper Responses to increasing cigarette prices in France: How did persistent smokers react?, Post-Print (2012) (2012)

2009

6. L'évaluation de la lutte antitabac: démêler une toile d'araignée avec des gants de boxe ?
   Regards croisés sur l'économie, 2009, n° 5, (1), 201-209

2008

7. Fitting observed and theoretical choices – women's choices about prenatal diagnosis of Down syndrome
   Health Economics, 2008, 17, (5), 557-577 View citations (8)

2007

8. Premières applications de la pharmacogénomique en oncologie. Stratégies industrielles et enjeux de régulation publique
   Revue d'économie industrielle, 2007, n° 120, (4), 13-13

1998

9. Down syndrome serum marker screening: decision criteria and implicit values
   Health Policy, 1998, 43, (1), 83-96 View citations (2)